Simvastatin decreases myocardial tumor necrosis factor α content in heart transplant recipients
- 31 January 2005
- journal article
- research article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 24 (1) , 46-51
- https://doi.org/10.1016/j.healun.2003.09.037
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Suppression of the Functionally Coupled Cyclooxygenase-2/Prostaglandin E Synthase as a Basis of Simvastatin-Dependent Plaque Stabilization in HumansCirculation, 2003
- Simvastatin Reduces the Expression of Adhesion Molecules in Circulating Monocytes From Hypercholesterolemic PatientsArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- High-Density Lipoproteins Protect Isolated Rat Hearts From Ischemia-Reperfusion Injury by Reducing Cardiac Tumor Necrosis Factor-α Content and Enhancing Prostaglandin ReleaseCirculation Research, 2003
- Simvastatin Initiated Early After Heart TransplantationCirculation, 2003
- Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipientsThe American Journal of Cardiology, 2001
- Simvastatin Reduces Graft Vessel Disease and Mortality After Heart TransplantationCirculation, 1997
- Effect of Pravastatin on Outcomes after Cardiac TransplantationNew England Journal of Medicine, 1995
- Basic Mechanisms in Congestive Heart FailureChest, 1994
- Cellular cholesterol metabolism in mitogen-stimulated lymphocytes — Requirement for de novo synthesisBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1990
- Role of mevalonic acid in the regulation of natural killer cell cytotoxicityJournal of Cellular Physiology, 1989